HALO vs HPQ · P/E 15, rev $857.7M vs P/E 8.6, rev $44.52B
Halozyme Therapeutics Inc (HALO) versus HP Inc (HPQ) — a side-by-side from cached financials, not a winner call.
Halozyme Therapeutics Inc (HALO) is a biotechnology company listed on US.
HP Inc (HPQ) is a computer hardware company listed on NYSE.
Latest reported HALO revenue for 2026-06-30 was $857.7M. Net income was $380.0M. HALO currently screens at market cap $7.10B and trailing P/E 15.3.
Latest reported HPQ revenue for 2026-07-31 was $44.52B. Net income was $1.66B. Revenue was up 54.3% from 2026-04-30 to 2026-07-31. HPQ currently screens at market cap $21.20B and trailing P/E 8.6.
HALO currently screens at market cap $7.10B and trailing P/E 15.3. HPQ currently screens at market cap $21.20B and trailing P/E 8.6.
Not investment advice. Open the HALO and HPQ stock pages for the full models.
Not investment advice.